Accuray is an international company that develops radiotherapy systems for alternative therapies for cancer and tumors in the body. It was founded in 1990 and is headquartered in Sunnyvale, California, USA.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Accuray news
27.04.2022
Accuray reported a GAAP loss of $1.895 million for the first nine months of fiscal year 2022, compared to a profit of $4.781 million in the previous year. Revenue increased 12.1% to $319.886 million from $285.353 million a year earlier.
Source: 
investors.accuray.com
investors.accuray.com
27.01.2022
Accuray reported a GAAP loss of $0.849 million for the first six months of FY2022, compared to a profit of $5.171 million in the previous year. Revenue increased 22.4% to $223.717 million from $182.791 million a year earlier.
Source: investors.accuray.com
investors.accuray.com
General information
| Company name | Accuray |
|---|---|
| Tags | #cancer treatment, #medical equipment |
| Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment |
| Business address | 1310 Chesapeake Terrace Sunnyvale, CA 94089 United States |
| Mailing address | 1310 Chesapeake Terrace Sunnyvale, CA 94089 United States |
| Website | investors.accuray.com |
English (US) 